SCHEMBL11047336

SCHEMBL11047336

CC(O)N(c1nc(N2CC[S+]([O-])CC2)c2ncnc(Sc3ccc(O)cc3)c2n1)C(C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11030374 0.92 CYP11B1 (0.33) —
SCHEMBL11026578 0.92 ALDH1A1 (0.31) —
SCHEMBL11026091 0.85 — —
SCHEMBL11049372 0.82 SLC29A1 (0.31) —
SCHEMBL10664690 0.81 — —
SCHEMBL11023388 0.80 CYP1A2 (0.38) —
SCHEMBL11048924 0.79 NPC1 (0.32) —
SCHEMBL11026413 0.79 SLC29A1 (0.41) —
SCHEMBL11023583 0.79 SLC29A1 (0.41) —
SCHEMBL11027014 0.77 TP53 (0.40) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4478833-A ANTICOAGULANTS DR. KARL THOMAE GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 1984-10-23 — — US disclosed
EP-0055444-A2 Trisubstituted pyrimido(5,4-d)pyrimidines, their preparation and medicaments containing them Dr. Karl Thomae GmbH (DE) 1982-07-07 — — EP disclosed
Send feedback